Nicoletta Colombo, MD, PhD, from the European Institute of Oncology in Milan, Italy discusses in this video "Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for persistent, recurrent, or metastatic cervical cancer: Randomized, double-blind, phase III KEYNOTE-826 study" presented at ESMO Congress 2021.
Ещё видео!